Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 13Obesity 6Weight Loss 5Overweight 3Menstruation Disturbances 2Intermittent Fasting 2Insulin Resistance 2Tumor Surgery 1Sarcopenia 1Postoperative Complications 1Obesity, Abdominal 1Muscle Weakness 1Motor Activity 1Moderately Overweight Individuals 1Metabolic Syndrome 1Metabolic Diseases 1Infertility 1Glucocorticoid Receptor Deficiency 1Fasting 1Esophageal Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1Breast Cancer Female 1Body Weight 1

Interventions

Standard of Care 1Robotic Surgical Procedures 1Practice Guidelines as Topic 1Monitoring, Physiologic 1Liraglutide 1Gastrectomy 1Esophagectomy 1Electroacupuncture 1Caloric Restriction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Obesity, Abdominal × Caloric Restriction × Clear all
NCT02449148 2022-01-13

HELENA

German Cancer Research Center

Phase NA Completed
150 enrolled
Other

Glucocorticoid Receptor Deficiency, Fasting, Metabolic Diseases, Obesity, Weight Loss, Obesity, Abdominal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡